June 22 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS INC SEES IPO OF UP TO 8.35 MILLION SHARES PRICED BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING
* FUSION PHARMACEUTICALS - TO USE ABOUT $30-$35 MILLION OF IPO PROCEEDS TO FUND DEVELOPMENT OF FPI-1434 MONOTHERAPY THROUGH PLANNED PHASE 2 CLINICAL TRIAL
* FUSION PHARMACEUTICALS - TO USE ABOUT $20-$25 MILLION OF IPO PROCEEDS TO ADVANCE FPI-1966 THROUGH PLANNED PHASE 1 CLINICAL TRIAL
* FUSION PHARMACEUTICALS - TO USE ABOUT $30-$35 MILLION OF IPO PROCEEDS TO FURTHER DEVELOP AND EXPAND PIPELINE Source: (https:// Further company coverage: FUSN.O